Insider Transactions in Q1 2023 at Axonics, Inc. (AXNX)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2023
|
Danny L. Dearen President & CFO |
SELL
Open market or private sale
|
Direct |
15,000
-21.5%
|
$825,000
$55.26 P/Share
|
|
Mar 31
2023
|
Danny L. Dearen President & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+12.63%
|
$195,000
$13.88 P/Share
|
|
Feb 21
2023
|
Rinda Sama Chief Operating Officer |
SELL
Open market or private sale
|
Indirect |
3,392
-84.8%
|
$189,952
$56.53 P/Share
|
|
Feb 21
2023
|
Rinda Sama Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
19,929
-13.81%
|
$1,116,024
$56.43 P/Share
|
|
Feb 01
2023
|
John Woock EVP, Chief Mktg/Strtgy Officer |
SELL
Open market or private sale
|
Direct |
3,979
-2.89%
|
$238,740
$60.73 P/Share
|
|
Feb 01
2023
|
Karen Noblett Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
931
-1.08%
|
$55,860
$60.73 P/Share
|
|
Feb 01
2023
|
Raymond W Cohen Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
8,117
-2.42%
|
$487,020
$60.73 P/Share
|
|
Feb 01
2023
|
Danny L. Dearen President & CFO |
SELL
Open market or private sale
|
Direct |
3,246
-6.05%
|
$194,760
$60.73 P/Share
|
|
Feb 01
2023
|
Alfred J Ford Jr Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
3,705
-3.43%
|
$222,300
$60.73 P/Share
|
|
Feb 01
2023
|
Rinda Sama Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
5,075
-3.16%
|
$304,500
$60.73 P/Share
|
|
Jan 31
2023
|
John Woock EVP, Chief Mktg/Strtgy Officer |
SELL
Open market or private sale
|
Direct |
7,570
-5.05%
|
$461,770
$61.14 P/Share
|
|
Jan 31
2023
|
John Woock EVP, Chief Mktg/Strtgy Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
22,125
+22.35%
|
-
|
|
Jan 31
2023
|
John Woock EVP, Chief Mktg/Strtgy Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,750
+13.78%
|
-
|
|
Jan 31
2023
|
Karen Noblett Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,703
-4.03%
|
$225,883
$61.14 P/Share
|
|
Jan 31
2023
|
Karen Noblett Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,250
+17.95%
|
-
|
|
Jan 31
2023
|
Karen Noblett Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+12.02%
|
-
|
|
Jan 31
2023
|
Raymond W Cohen Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
22,904
-6.16%
|
$1,397,144
$61.14 P/Share
|
|
Jan 31
2023
|
Raymond W Cohen Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
61,968
+24.44%
|
-
|
|
Jan 31
2023
|
Raymond W Cohen Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,750
+13.8%
|
-
|
|
Jan 31
2023
|
Danny L. Dearen President & CFO |
SELL
Open market or private sale
|
Direct |
10,511
-14.86%
|
$641,171
$61.14 P/Share
|
|
Jan 31
2023
|
Danny L. Dearen President & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,250
+40.08%
|
-
|
|
Jan 31
2023
|
Danny L. Dearen President & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+28.57%
|
-
|
|
Jan 31
2023
|
Alfred J Ford Jr Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
6,234
-5.25%
|
$380,274
$61.14 P/Share
|
|
Jan 31
2023
|
Alfred J Ford Jr Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,500
+21.35%
|
-
|
|
Jan 31
2023
|
Alfred J Ford Jr Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,500
+14.49%
|
-
|
|
Jan 31
2023
|
Rinda Sama Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
13,425
-7.39%
|
$818,925
$61.14 P/Share
|
|
Jan 31
2023
|
Rinda Sama Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,875
+24.67%
|
-
|
|
Jan 31
2023
|
Rinda Sama Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,750
+12.13%
|
-
|
|
Jan 17
2023
|
John Woock EVP, Chief Mktg/Strtgy Officer |
SELL
Open market or private sale
|
Direct |
30,215
-12.98%
|
$2,024,405
$67.44 P/Share
|
|
Jan 17
2023
|
John Woock EVP, Chief Mktg/Strtgy Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,215
+10.79%
|
$302,150
$10.69 P/Share
|
|
Jan 13
2023
|
Alfred J Ford Jr Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
36,015
-19.9%
|
$2,376,990
$66.59 P/Share
|
|
Jan 13
2023
|
Alfred J Ford Jr Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
36,015
+13.03%
|
$360,150
$10.77 P/Share
|
|
Jan 13
2023
|
Raymond W Cohen Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
40,736
-14.66%
|
$2,647,840
$65.9 P/Share
|